Retrospective Study
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Sep 26, 2023; 15(9): 439-447
Published online Sep 26, 2023. doi: 10.4330/wjc.v15.i9.439
Immediate in-hospital outcomes after percutaneous revascularization of acute myocardial infarction complicated by cardiogenic shock
Bashir Ahmed Solangi, Jehangir Ali Shah, Rajesh Kumar, Mahesh Kumar Batra, Gulzar Ali, Muhammad Hassan Butt, Ambreen Nisar, Nadeem Qamar, Tahir Saghir, Jawaid Akbar Sial
Bashir Ahmed Solangi, Jehangir Ali Shah, Rajesh Kumar, Mahesh Kumar Batra, Gulzar Ali, Muhammad Hassan Butt, Ambreen Nisar, Nadeem Qamar, Tahir Saghir, Jawaid Akbar Sial, Department of Adult Cardiology, National Institute of Cardiovascular Diseases, Karachi 75510, Pakistan
Author contributions: Solangi BA, Shah JA, Kumar R, Batra MK, Ali G, Butt MH, and Nisar A contributed to the concept and design of study; Saghir T, Sial JA, and Qamar N contributed to the analysis and interpretation of data; Solangi BA, Shah JA, Kumar R, Batra MK, Ali G, Nisar A, and Butt MH collected data and drafted the manuscript; Saghir T, Sial JA, and Qamar N critically analysed for content; All author approved the final draft of the manuscript.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the National Institute of Cardiovascular Diseases (NICVD), Karachi.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: All authors have no conflict of interest to disclose.
Data sharing statement: Data and material will be available upon request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bashir Ahmed Solangi, FCPS, Associate Professor, Department of Adult Cardiology, National Institute of Cardiovascular Diseases, Rafiqi H.J. Shaheed Road, Karachi 75510, Pakistan. bashir1981.ba@gmail.com
Received: June 9, 2023
Peer-review started: June 9, 2023
First decision: July 19, 2023
Revised: July 31, 2023
Accepted: August 29, 2023
Article in press: August 29, 2023
Published online: September 26, 2023
Processing time: 103 Days and 21.5 Hours
ARTICLE HIGHLIGHTS
Research background

Cardiogenic shock (CS) is a life-threatening complication of acute myocardial infarction with high morbidity and mortality rates.

Research motivation

The management of CS requires a multidisciplinary approach involving cardiology, critical care, and interventional teams. Early identification and diagnosis of CS is crucial, as early interventions have been shown to improve survival rates.

Research objectives

This study aimed to investigate the immediate mortality rates in patients with CS undergoing primary percutaneous coronary intervention (PCI) and identify mortality predictors.

Research methods

We conducted a retrospective analysis of 305 patients with CS who underwent primary PCI and immediate mortality rate was analyzed.

Research results

In a sample of 305 patients, the immediate mortality rate was found to be 54.8% with Killip class IV at presentation, multivessel disease, and high thrombus burden as independent predictors of immediate mortality.

Research conclusions

Immediate mortality rate in patients with CS undergoing primary PCI remains high despite advances in treatment strategies. Killip class IV at presentation, multivessel disease, and high thrombus burden (grade ≥ 4) were identified as independent predictors of immediate mortality.

Research perspectives

These findings underscore the need for aggressive management and close monitoring of patients with CS undergoing primary PCI, particularly in those with these high-risk characteristics.